Asthma trials in Argentina

In Argentina 19 Also abroad 500

19 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
CABA, Mendoza, Rosario
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Rosario
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Buenos Aires, CABA, Florida, Lanus, Lobos, Mendoza, Quilmes, Rosario
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Buenos Aires, Florida, Lobos, Mar del Plata, Mendoza, Rosario, San Juan Bautista
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Buenos Aires, Ciudad Autonoma de Buenos Aires, Mar del Plata, Mendoza, Rosario, San Miguel de Tucumán
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 2Taking people
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Where
Buenos Aires, Ciudad de Buenos Aires, Corrientes, Granadero Baigorria, Mar del Plata, Río Cuarto, Rosario, Santa Fe
Age
18 years to 75 years
People
531 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07219173
Phase 3Taking people
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Where
Buenos Aires, Ciudad Autonoma de Buenos Aire, Lujan de Cuyo
Age
18 years and over
People
110 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07645248
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Where
Buenos Aires, Ciudad Autónoma de Buenos Aires, Concepción del Uruguay, Mar del Plata, Mendoza, Rosario, San Miguel de Tucumán, San Salvador, Santa Fe
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07359846
Phase 2Taking people
A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
Where
Buenos Aires, Córdoba, Mendoza, Rosario, Santa Fe
Age
18 years to 85 years
People
440 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07746687 · EU 2026-526262-24-00
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
CABA, Ciudad de Buenos Aires, La Plata, Mendoza, Rosario, San Miguel de Tucumán
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
Phase 2Taking people
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Where
Buenos Aires, Córdoba, Paraná, Rosario, San Miguel de Tucumán, Santa Fe
Age
18 years to 75 years
People
600 worldwide
Run by
Windward Bio
See details and how to joinNCT07120503 · EU 2025-521391-58-00
No phaseTaking people
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
Where
Buenos Aires, Medoza
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07245576
Phase 2Taking people
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Where
Buenos Aires, CABA, Lanús Este, La Plata, Lobos, Mar del Plata, Mendoza, Rosario, San Juan Bautista, Santa Fe
Age
4 years to 11 years
People
69 worldwide
Run by
AstraZeneca
See details and how to joinNCT07525375 · EU 2025-524914-26-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Buenos Aires, Concepción del Uruguay, Lobos, Mar del Plata, Quilmes, Rosario, San Miguel de Tucumán
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Berazategui, Buenos Aires, La Plata, Buenos Aires, Lobos, Mendoza, Rosario, San Miguel de Tucumán, Santa Fe
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Buenos Aires, Córdoba, Corrientes, Mendoza, Rosario
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 2Taking people
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Where
Buenos Aires, Ciudad Autonoma de Buenos Aire, Córdoba, La Plata, Mendoza, Quilmes, Rosario, San Juan Bautista, San Miguel de Tucumán, Santa Fe
Age
18 years to 75 years
People
780 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00
Phase 3Taking people
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Where
Buenos Aires, Nueve de Julio, Rosario
Age
12 years to 65 years
People
736 worldwide
Run by
Inmunotek S.L.
See details and how to joinNCT07348302
Phase 2/3Not yet taking people in Argentina
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Where
Buenos Aires
Age
12 years to 60 years
People
90
Run by
Inmunotek S.L.
See details and how to joinNCT05641272